AeroLeads people directory · profile
Michael Binks Email & Phone Number
Chief Medical Officer
at
Capricor Therapeutics, Inc.
2 work emails found
@gsk.com
3 phones found area 617 and 212
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Medical Officer
Location
Cambridge, Massachusetts, United States
Who is Michael Binks? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael Binks is listed as Chief Medical Officer at Capricor Therapeutics, Inc., based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at gsk.com, phone signal with area code 617, 212, and a matched LinkedIn profile for Michael Binks.
Michael Binks previously worked as Founder at Pathfindrx and VP and Head of Rare Disease Clinical Research, RDRU, Worldwide Research and Development at Pfizer. Michael Binks holds Bsc, Immunopharmacology from Ucl.
Company email context
Email format at Capricor Therapeutics, Inc.
This section adds company-level context without repeating Michael Binks's masked contact details.
{first}.{last}@gsk.com
89% confidence
AeroLeads found 2 current-domain work email signals for Michael Binks. Compare company email patterns before reaching out.
Profile bio
About Michael Binks
A scientifically focused, creative and seasoned drug developer with 23 years of experience in escalating leadership roles in major global pharmaceutical companies. A clinical rheumatologist with a background in academic immunology research. Particular focus on drug discovery and pharmacological translation across multiple biologies and modalities. Passionate about innovation and efficient execution in translation and early clinical development, through novel endpoint and clinical program design. Expertise in auto-immune diseases, inflammation and in multiple rare disease therapeutic areas.Key contributions made to initiation of internal and external new target programs, biological rationale, disease alignment, regulatory data packages, clinical and translational plans for multiple candidate compounds (small molecule, biological and AAV), >15 FTIH programs, clinical lead for >12 PoC, and multiple exploratory clinical studies. Major contributions made to 3 products including Paxlovid; and 6 current Phase 3 development assets.KEY SKILLSETS/COMPETENCIES: •Multi-disciplinary line leadership: including physicians, clinical scientists, biologists, pharmacologists, pharmacokineticists, project leaders and chemists. Line groups between 12-60 people. Empowering, enabling style.•Program/Project leadership: leadership of LO, pre-clinical and clinical projects, of multiple modalities (small molecule, biological and gene therapy)•Matrix management: experienced leader of matrix groups with oversight of target identification and validation, lead optimisation, candidate selection and clinical phases. Chair of disease area science fora, clinical research and technical review committees.•Clinical insight: in depth knowledge of clinical features and pathophysiology of rheumatological, other autoimmune disease. Expertise in hematological, neurologic, cardiac and renal adult and pediatric rare diseases. Expertise in clinical and biomarker endpoint development, innovative Phase I/II clinical trial design•External interface management: Joint Steering committee leadership for 5 commercial external drug discovery alliances (small molecule, biologic, oligonucleotides and gene editing). Industry co-chairperson for Medical Research Council / ABPI consortium on early rheumatoid arthritis. JSC for cTAP consortium and drug development round table in DMD. Integration leadership of 2 company acquisitions. Leadership of pre-clinical gene therapy portfolio outlicensing.
Listed skills include Clinical Trials, Immunology, Clinical Development, Translational Medicine, and 36 others.
Current workplace
Michael Binks's current company
Company context helps verify the profile and gives searchers a useful next step.
13 roles · 34 years
Michael Binks work experience
A career timeline built from the work history available for this profile.
Founder
CurrentApplication of novel methodology and technology to drug discovery, delivery, translation, and clinical development in immunological and rare diseases to accelerate development and improve the probability of success of novel therapeutics with potential to transform clinical outcomes.
Jan 2024 - Present
Vp And Head Of Rare Disease Clinical Research, Rdru, Worldwide Research And Development
Leader of Clinical Research function across Rare Diseases at Pfizer. Focused on rare hematology, rare neuromuscular and neurological and rare endocrine/metabolic diseases. Management of clinical research group of talented MDs, MD/PhDs and non-MD clinicians responsible for clinical development plans, clinical study design and medical oversight. Governance.
Feb 2014 - Dec 2023
Head, Translational Medicine, Emu, Epinova And Kiinib Dpus, Immuno-Inflammation Therapy Area
Translational Medicine lead for new drug discovery business units. Small team of clinicians and scientists accountable for clinical translation of novel target classes in epigenetics, and JAK inhibitors. Business (JSC) and scientific oversight of 4 multi-target biotech drug discovery alliances. Co-chair UK MRC early arthritis consortium. Development of.
Jan 2009 - Dec 2013
Head, Immuno-Epigenetics Dpu, Immuno-Inflammation Cedd, R+D
Establishment of new department for drug discovery in immuno-epigenetics 35-60 scientists. Development of scientific, clinical and business strategy for CEDD. Budget holder.
Apr 2008 - 2009
Head, Experimental Biomedicine, Immuno-Inflammation Centre Of Excellence For Drug Discovery
Establishment of new department for translational medicine for immune mediated inflammatory disease (biomarkers, imaging, animal models, ex vivo disease tissue models) Development of scientific, clinical and business strategy for CEDD. Development of academic and commercial alliances.
Oct 2007 - Mar 2008
Head, Rheumatoid Arthritis Disease Biology, Drug Discovery
Leadership of 25 basic and 2 clinical scientists dedicated to the discovery and early development of novel therapeutics for rheumatoid arthritis. Program leader. Lead biologist / rheumatologist in genetic study of RA. Accountable for target selection and validation, lead optimization biology, development of pharmacodynamic markers and imaging. Clinical.
Aug 2001 - Sep 2007
Senior Research Physician, Clinical Pharmacology
Induction into industry. Training in statistics, Good Clinical Practice (GCP), clinical trial design. Support for rheumatology small molecule projects.
Jan 2000 - Jul 2001
Honorary Clinical Fellow, Dept Of Rheumatology
Addenbrookes Hospital, Cambridge
Clinical session in SLE and Connective Tissue Disease clinic 1-2 x / month
2006 - 2011
~5 yrs
Visiting Rheumatologist
General rheumatology clinic with scleroderma. 1 session / week. 250 new patients per year.
2000 - 2003
~3 yrs
Senior Registrar, Rheumatology
Senior Registrar in General Rheumatology for Professor Carol Black. Extensive experience in the management of connective tissue disease, and scleroderma in particular. Key contributions to clinical trial of autologous stem cell transplantation for the treatment of severe diffuse scleroderma.
Aug 1997 - Dec 1999
Honorary Lecturer In Immunology
1993 - 1999
~6 yrs
Arthritis Research Council And Jules Thorn Clinical Research Fellow
Studies of cell biology and function of human tonsillar and monocyte derived dendritic cell antigen presentation in vitro.
1992 - 1997
~5 yrs
5 education records
Michael Binks education
Bsc, Immunopharmacology
Ucl
Mb, Bs, Medicine
Ucl
Mrcp, Internal Medicine
Royal College Of Physicians, London
Ccst (Rheumatology Specialist Accreditation)
General Medical Council
Education record
Robert Gordon'S College, Aberdeen
FAQ
Frequently asked questions about Michael Binks
Quick answers generated from the profile data available on this page.
What company does Michael Binks work for?
Michael Binks works for Capricor Therapeutics, Inc..
What is Michael Binks's role at Capricor Therapeutics, Inc.?
Michael Binks is listed as Chief Medical Officer at Capricor Therapeutics, Inc..
What is Michael Binks's email address?
AeroLeads has found 2 work email signals at @gsk.com for Michael Binks at Capricor Therapeutics, Inc..
What is Michael Binks's phone number?
AeroLeads has found 3 phone signal(s) with area code 617, 212 for Michael Binks at Capricor Therapeutics, Inc..
Where is Michael Binks based?
Michael Binks is based in Cambridge, Massachusetts, United States while working with Capricor Therapeutics, Inc..
What companies has Michael Binks worked for?
Michael Binks has worked for Capricor Therapeutics, Inc., Pathfindrx, Pfizer, Glaxosmithkline, and Addenbrookes Hospital, Cambridge.
How can I contact Michael Binks?
You can use AeroLeads to view verified contact signals for Michael Binks at Capricor Therapeutics, Inc., including work email, phone, and LinkedIn data when available.
What schools did Michael Binks attend?
Michael Binks holds Bsc, Immunopharmacology from Ucl.
What skills is Michael Binks known for?
Michael Binks is listed with skills including Clinical Trials, Immunology, Clinical Development, Translational Medicine, Drug Discovery, Biomarkers, Drug Development, and Clinical Research.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial